126 related articles for article (PubMed ID: 25627040)
1. Dysregulation of redox-state-regulating enzymes in melanocytic skin tumours and the surrounding microenvironment.
Hintsala HR; Soini Y; Haapasaari KM; Karihtala P
Histopathology; 2015 Sep; 67(3):348-57. PubMed ID: 25627040
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 2 and 9 in lentigo maligna melanoma.
Bongiorno MR; Doukaki S; Ferro G; Aricò M
G Ital Dermatol Venereol; 2009 Jun; 144(3):327-9. PubMed ID: 19528914
[No Abstract] [Full Text] [Related]
3. Surface microscopy of naevi and melanomas--clues to melanoma.
Nilles M; Boedeker RH; Schill WB
Br J Dermatol; 1994 Mar; 130(3):349-55. PubMed ID: 8148277
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen receptor-beta expression in melanocytic lesions.
Schmidt AN; Nanney LB; Boyd AS; King LE; Ellis DL
Exp Dermatol; 2006 Dec; 15(12):971-80. PubMed ID: 17083364
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
6. Fascin expression in melanocytic lesions of the skin.
YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
9. [Dubreuilh melanoma: and epidemiologic and prognostic study].
Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
11. Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
J Cutan Pathol; 1998 Apr; 25(4):204-9. PubMed ID: 9609139
[TBL] [Abstract][Full Text] [Related]
12. Current diagnostic problems in melanoma pathology.
Ruiter DJ; van Dijk MC; Ferrier CM
Semin Cutan Med Surg; 2003 Mar; 22(1):33-41. PubMed ID: 12773012
[TBL] [Abstract][Full Text] [Related]
13. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions].
Collina G
Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373
[No Abstract] [Full Text] [Related]
14. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
[TBL] [Abstract][Full Text] [Related]
15. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
16. The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.
Mishra M; Jiang H; Wu L; Chawsheen HA; Wei Q
Cancer Lett; 2015 Oct; 366(2):150-9. PubMed ID: 26170166
[TBL] [Abstract][Full Text] [Related]
17. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.
Merikallio H; Pääkkö P; Kinnula VL; Harju T; Soini Y
Hum Pathol; 2012 Apr; 43(4):577-84. PubMed ID: 21943684
[TBL] [Abstract][Full Text] [Related]
19. Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions.
Magro CM; Crowson AN; Desman G; Zippin JH
Arch Dermatol; 2012 Mar; 148(3):335-44. PubMed ID: 22105816
[TBL] [Abstract][Full Text] [Related]
20. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
Arlette JP; Trotter MJ; Trotter T; Temple CL
J Surg Oncol; 2004 Jul; 86(4):179-86. PubMed ID: 15221924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
